{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-004669","form_type":"8-K","ticker":"MODD","cik":"0001074871","company_name":"Modular Medical, Inc.","filed_at":"2024-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.299611+00:00","generated_at":"2026-06-06T20:59:21.742131+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Modular Medical submits MODD1 insulin pump to FDA for 510(k) clearance","bullets":["Submitted MODD1 next-generation insulin pump to FDA for 510(k) clearance on Jan 19, 2024.","Expects initial FDA questions during quarter ending June 30, 2023 (as stated in press release).","Plans to file for UKCA mark to market MODD1 in the United Kingdom.","CEO Jeb Besser and Chairman Paul DiPerna highlighted simplified design to boost pump adoption."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-004669","json":"https://secwatch.observer/filing/0001213900-24-004669.json","markdown":"https://secwatch.observer/filing/0001213900-24-004669.md","text":"https://secwatch.observer/filing/0001213900-24-004669.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1074871/000121390024004669/0001213900-24-004669-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1074871/000121390024004669/ea191833-8k_modular.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T20:59:21.742131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}